{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T18:22:39Z","timestamp":1793902959337,"version":"4.8.0"},"reference-count":39,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2010,11,2]],"date-time":"2010-11-02T00:00:00Z","timestamp":1288656000000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Academic Emergency Medicine"],"published-print":{"date-parts":[[2010,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Objectives:\u2002<\/jats:bold>This study was conducted to test the hypothesis that opioid receptor (OR)\u2010mediated cardioprotection is agonist specific when administered prior to coronary artery occlusion and reperfusion in a rat model.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold>Anesthetized open\u2010chest male Wistar rats were subjected to 45\u2003minutes of left coronary artery occlusion and 2\u2003hours of reperfusion. Opioid agonists were infused 15\u2003minutes prior to coronary artery occlusion. Two control groups and 15 opioid\u2010treated groups were studied. Controls were infused with either saline alone (<jats:italic>n\u2003=\u2003<\/jats:italic>16) or dimethyl sulfoxide plus hydroxypropyl\u2010\u03b2\u2010cyclodextrin in saline (<jats:italic>n\u2003=\u2003<\/jats:italic>19). The \u03bc\u2010selective agonist DAMGO was infused at either 150\u2003nmol\/kg (<jats:italic>n\u2003=\u2003<\/jats:italic>15) or 1500\u2003nmol\/kg (<jats:italic>n\u2003=\u2003<\/jats:italic>14), and dermorphin\u2010H was infused at 150\u2003nmol\/kg (<jats:italic>n\u2003=\u2003<\/jats:italic>14). The \u03b4<jats:sub>1<\/jats:sub>\u2010selective agonist<jats:sc>d\u2010<\/jats:sc>Pen<jats:sup>2,5<\/jats:sup>enkephalin (DPDPE) was infused at 150\u2003nmol\/kg (<jats:italic>n\u2003=\u2003<\/jats:italic>16) or 1500\u2003nmol\/kg (<jats:italic>n\u2003=\u2003<\/jats:italic>14). The \u03b4<jats:sub>2<\/jats:sub>\u2010selective agonists deltorphin\u2003II (<jats:italic>n\u2003=\u2003<\/jats:italic>16), deltorphin\u2010D<jats:sub>variant<\/jats:sub>(<jats:italic>n\u2003=\u2003<\/jats:italic>15), and deltorphin\u2010E (<jats:italic>n\u2003=\u2003<\/jats:italic>14) were infused at 150\u2003nmol\/kg. The selective \u03ba<jats:sub>1<\/jats:sub>opioid agonist U\u201050488 was infused at 240\u2003nmol\/kg (<jats:italic>n\u2003=\u2003<\/jats:italic>14), 1500\u2003nmol\/kg (<jats:italic>n\u2003=\u2003<\/jats:italic>14), and 2,400\u2003nmol\/kg (<jats:italic>n\u2003=\u2003<\/jats:italic>14). The selective \u03ba<jats:sub>2<\/jats:sub>opioid agonist GR\u201089696 was infused at 150\u2003nmol\/kg (<jats:italic>n\u2003=\u2003<\/jats:italic>14) and 1500\u2003nmol\/kg (<jats:italic>n\u2003=\u2003<\/jats:italic>15). Orphinan FQ (nociceptin), also referred to as OR\u2010like 1 (ORL1), was infused at 220\u2003nmol\/kg (<jats:italic>n\u2003=\u2003<\/jats:italic>15) and 1500\u2003nmol\/kg (<jats:italic>n\u2003=\u2003<\/jats:italic>15). The infarct size\/area at risk (IS\/AAR) ratio was determined after reperfusion by negative staining with patent blue violet dye. Hemodynamic parameters including heart rate, mean arterial blood pressure (MAP), and rate pressure product (RPP) were determined.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold>Pretreatment with the \u03b4<jats:sub>2<\/jats:sub>OR agonist deltorphin\u2003II (150\u2003nmol\/kg) significantly reduced the IS\/AAR ratio, while deltorphin\u2010D<jats:sub>variant<\/jats:sub>and deltorphin\u2010E did not exhibit an infarct\u2010sparing effect at that treatment dose. Activation of \u03b4<jats:sub>1<\/jats:sub>OR by DPDPE, \u03ba<jats:sub>1<\/jats:sub>OR by U\u201050488, \u03ba<jats:sub>2<\/jats:sub>OR by GR\u201089696, \u03bc OR by DAMGO, dermorphin\u2010H, and nociceptin had no effect on the IS\/AAR ratio. U\u201050488 at 2,400\u2003nmol\/L induced a bradycardic effect. All other opioids had no effect on hemodynamic parameters at the doses tested.<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold>Peripheral \u03b4<jats:sub>2<\/jats:sub>OR activation by deltorphin\u2003II induces infarct size reduction in this animal model. Agonists of \u03bc, \u03b4<jats:sub>1<\/jats:sub>, \u03ba<jats:sub>1<\/jats:sub>, \u03ba<jats:sub>2<\/jats:sub>, and nociceptin receptors at the doses tested did not induce cardiac tolerance to ischemia\/reperfusion injury in vivo.<\/jats:p><jats:p>ACADEMIC EMERGENCY MEDICINE 2010; 17:1239\u20131246 \u00a9 2010 by the Society for Academic Emergency Medicine<\/jats:p>","DOI":"10.1111\/j.1553-2712.2010.00910.x","type":"journal-article","created":{"date-parts":[[2010,11,3]],"date-time":"2010-11-03T17:56:52Z","timestamp":1288807012000},"page":"1239-1246","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Comparative Analysis of the Cardioprotective Properties of Opioid Receptor Agonists in a Rat Model of Myocardial Infarction"],"prefix":"10.1111","volume":"17","author":[{"given":"Leonid N.","family":"Maslov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yury B.","family":"Lishmanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter R.","family":"Oeltgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva I.","family":"Barzakh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey V.","family":"Krylatov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia V.","family":"Naryzhnaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian\u2010Ming","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen A.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,11,2]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1006\/jmcc.1997.0454"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00843.2002"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.1998.274.3.H909"},{"key":"e_1_2_8_5_2","doi-asserted-by":"crossref","first-page":"H1346","DOI":"10.1152\/ajpheart.2001.280.3.H1346","article-title":"Essential activation of PKC\u2010\u03b4 in opioid\u2010initiated cardioprotection","volume":"280","author":"Fryer RM","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.01045.2001"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardiores.2003.10.008"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.97.13.1282"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.2001.280.1.H384"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-200403000-00012"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00380-007-0983-z"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.01004.2002"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.84.12.1388"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0704945"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s003950050001"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00839539"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5273(93)90269-M"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02447158"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(03)00348-5"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0705475"},{"key":"e_1_2_8_21_2","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/S0022-3565(25)24051-4","article-title":"Binding affinity and selectivity of opioids at mu, delta and kappa receptors in monkey brain membranes","volume":"271","author":"Emmerson PJ","year":"1994","journal-title":"J Pharmacol Exp Ther."},{"key":"e_1_2_8_22_2","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/S0026-895X(25)09622-1","article-title":"The third extracellular loop of the human \u03b4\u2010opioid receptor determines the selectivity of \u03b4\u2010opioid agonists","volume":"50","author":"Varga EV","year":"1996","journal-title":"Mol Pharmacol."},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(91)90604-Z"},{"key":"e_1_2_8_24_2","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0022-3565(25)20256-7","article-title":"Lack of antinociceptive cross\u2010tolerance between [D\u2010Pen2,D\u2010Pen5]enkephalin and [D\u2010Ala2]deltorphin\u2003II in mice: evidence for delta receptor subtypes","volume":"258","author":"Mattia A","year":"1991","journal-title":"J Pharmacol Exp Ther."},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(85)90431-5"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1991.tb09869.x"},{"key":"e_1_2_8_27_2","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0022-3565(24)29474-X","article-title":"GR 89,696: a potent kappa\u2010opioid agonist with subtype selectivity in rhesus monkeys","volume":"298","author":"Butelman ER","year":"2001","journal-title":"J Pharmacol Exp Ther."},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/377532a0"},{"key":"e_1_2_8_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2009.02.016"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00842476"},{"key":"e_1_2_8_31_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.1994.267.1.E124"},{"key":"e_1_2_8_32_2","doi-asserted-by":"publisher","DOI":"10.1213\/01.ANE.0000105878.96434.05"},{"key":"e_1_2_8_33_2","doi-asserted-by":"publisher","DOI":"10.1213\/ane.0b013e3181884ba6"},{"key":"e_1_2_8_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10525-005-0008-3"},{"key":"e_1_2_8_35_2","first-page":"26","article-title":"[Delta \u2010opioid receptor agonists prevent the irreversible damage of cardiomyocytes in ischemic perfused rat heart] (Russian)","volume":"67","author":"Platonov AA","year":"2004","journal-title":"Exp Clin Pharmacol."},{"key":"e_1_2_8_36_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199504000-00004"},{"key":"e_1_2_8_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/0196-9781(86)90223-8"},{"key":"e_1_2_8_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/28.10.1574"},{"key":"e_1_2_8_39_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10517-007-0007-0"},{"key":"e_1_2_8_40_2","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/shk.0b013e31805cdb70","article-title":"Post\u2010treatment with the novel deltorphin E, a delta2 opioid receptor agonist, increases recovery and survival after severe hemorrhagic shock in rats","volume":"29","author":"Rutten M","year":"2008","journal-title":"Shock."}],"container-title":["Academic Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1553-2712.2010.00910.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1553-2712.2010.00910.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T15:29:59Z","timestamp":1740670199000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1553-2712.2010.00910.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["10.1111\/j.1553-2712.2010.00910.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1553-2712.2010.00910.x","archive":["Portico"],"relation":{},"ISSN":["1069-6563","1553-2712"],"issn-type":[{"value":"1069-6563","type":"print"},{"value":"1553-2712","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11]]},"assertion":[{"value":"2010-11-02","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}